Prokineticin-2, motilin, ghrelin and metoclopramide: Prokinetic utility in mouse stomach and colon

被引:52
作者
Bassil, AK
Dass, NB
Murray, CD
Muir, A
Sanger, GJ
机构
[1] GlaxoSmithKline Inc, Neurol & Gastrointestinal Ctr Excellence Drug Dis, Harlow, Essex, England
[2] St Marks Hosp, Dept Physiol, Harrow, Middx, England
[3] GlaxoSmithKline Inc, Discovery Res, Harlow, Essex, England
关键词
gastrointestinal motility; ghrelin; metoclopramide; motilin; prokineticin;
D O I
10.1016/j.ejphar.2005.09.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability of agents described as gastrointestinal prokinetics (prokineticin-2, [Nle(13)]-motilin, ghrelin), to modulate nerve-mediated contractions of mouse isolated stomach and colon was determined and compared with the prokinetic and 5-HT4 receptor agonist, metoclopramide. Circular muscle preparations were electrically field-stimulated (EFS) to evoke cholinergically mediated contractions. Metoclopramide 10-100 mu M facilitated EFS-evoked contractions in forestomach (n=5-11,P<0.05); 1 mM inhibited. Metoclopramide had no effects in colon, apart from 100 mu M which reduced contractions. Prokineticin-2 0.001 nM-0.1 mu M (n=3-7) or [Nle(13)]-motilin 0.1 nM-1 mu M (n=4-8) had no effects in forestomach or colon. Ghrelin 0.01-1 mu M facilitated EFS-evoked contractions in forestomach (n=5-7, P< 0.05) but not in colon (n=5-8). We conclude that ghrelin and metoclopramide facilitate excitatory nerve activity because neither affected inhibitory responses to EFS in the presence of atropine, or contractions to carbachol. Further, prokineticin-2 and [Nle(13)]-motilin are unlikely to exert gastric prokinetic activity in this species, the inactivity of the latter being consistent with an absence of the motilin receptor in rodents. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:138 / 144
页数:7
相关论文
共 49 条
[1]  
Aerssens J., 2004, NEUROGASTROENT MOTIL, V16, P841
[2]  
[Anonymous], 5HT4 RECEPTORS BRAIN
[3]   Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin [J].
Asakawa, A ;
Inui, A ;
Kaga, T ;
Yuzuriha, H ;
Nagata, T ;
Ueno, N ;
Makino, S ;
Fujimiya, M ;
Niijima, A ;
Fujino, MA ;
Kasuga, M .
GASTROENTEROLOGY, 2001, 120 (02) :337-345
[4]  
BASSIL AK, 2003, NEUROGASTROENT MOTIL, V15, P20
[5]   ACTION OF SOME NATURAL PEPTIDES ON STOMACH OF ANESTHETIZED RAT [J].
BERTACCINI, G ;
CORUZZI, G .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 298 (02) :163-166
[6]   REGIONALLY SELECTIVE CHOLINERGIC STIMULATION BY BRL-24924 IN THE HUMAN ISOLATED GUT [J].
BURKE, TA ;
SANGER, GJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (03) :261-265
[7]  
BURLEIGH DE, 1985, BRIT J CLIN PHARMACO, V20, P475
[8]   Indirect parasympathomimetic activity of metoclopramide: Reversible inhibition of cholinesterases from human central nervous system and blood [J].
Chemnitius, JM ;
Haselmeyer, KH ;
Gonska, BD ;
Kreuzer, H ;
Zech, R .
PHARMACOLOGICAL RESEARCH, 1996, 34 (1-2) :65-72
[9]   Long-term effects of synaptic activation at low frequency on excitability of myenteric AH neurons [J].
Clerc, N ;
Furness, JB ;
Kunze, WAA ;
Thomas, EA ;
Bertrand, PP .
NEUROSCIENCE, 1999, 90 (01) :279-289
[10]  
CRAIG DA, 1990, J PHARMACOL EXP THER, V252, P1378